Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | LYPLA2 |
| Upstream (Parents) |
|---|
| (<<) ATP2C2 → LYPLA2 |
| (<<) CKB → LYPLA2 |
| (<<) DVL1 → LYPLA2 |
| (<<) EPHB4 → LYPLA2 |
| (<<) ERBB2 → LYPLA2 |
| (<<) ERBB3 → LYPLA2 |
| (<<) FAM131C → LYPLA2 |
| (<<) GLTPD1 → LYPLA2 |
| (<<) GNB1 → LYPLA2 |
| (<<) KLF16 → LYPLA2 |
| (<<) LIMK1 → LYPLA2 |
| (<<) NR3C1 → LYPLA2 |
| (<<) PAK4 → LYPLA2 |
| (<<) PPP1R3D → LYPLA2 |
| (<<) PRR7 → LYPLA2 |
| (<<) PTGS2 → LYPLA2 |
| (<<) RORA → LYPLA2 |
| (<<) SPDEF → LYPLA2 |
| (<<) STX1A → LYPLA2 |
| (<<) ZFPM1 → LYPLA2 |
| Downstream (Children) |
|---|
| LYPLA2 → ARL4C (>>) |
| LYPLA2 → CALML5 (>>) |
| LYPLA2 → CAV3 (>>) |
| LYPLA2 → LIPG (>>) |
| LYPLA2 → MEF2A (>>) |
| LYPLA2 → MMP15 (>>) |
| LYPLA2 → MRAS (>>) |
| LYPLA2 → RPL22L1 (>>) |
| LYPLA2 → RPS6KA1 (>>) |
| LYPLA2 → SLC6A14 (>>) |
